Systemic embolism in amyloid transthyretin cardiomyopathy

AIMS: Although systemic embolism is a potential complication in transthyretin amyloid cardiomyopathy (ATTR‐CM), data about its incidence and prevalence are scarce. We studied the incidence, prevalence and factors associated with embolic events in ATTR‐CM. Additionally, we evaluated embolic events ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilches, Silvia, Fontana, Marianna, Gonzalez‐Lopez, Esther, Mitrani, Lindsey, Saturi, Giulia, Renju, Mary, Griffin, Jan M., Caponetti, Angelo, Gnanasampanthan, Sahana, De los Santos, Jeffeny, Gagliardi, Christian, Rivas, Adrian, Dominguez, Fernando, Longhi, Simone, Rapezzi, Claudio, Maurer, Mathew S., Gillmore, Julian, Garcia‐Pavia, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Cardiac Amyloidosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542906/
https://www.ncbi.nlm.nih.gov/pubmed/35650018
http://dx.doi.org/10.1002/ejhf.2566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542906/
https://www.ncbi.nlm.nih.gov/pubmed/35650018
http://dx.doi.org/10.1002/ejhf.2566

Ejemplares similares